Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65694 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Darunavir
CAS:<p>Applications Second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral. It is a COVID19-related research product.<br>References Koh, Y., et al.: Antimicrob. Agents Chemother., 47, 3123 (2003), Arasteh, K., et al.: AIDS, 19, 943 (2005), Surleraux, D.L.N.G., et al.: J. Med. Chem., 48, 1813 (2005),<br></p>Formula:C27H37N3O7SColor and Shape:BeigeMolecular weight:547.66Pseudo Vardenafil
CAS:<p>Applications Vardenafil analog.<br>References Blok-Tip, L., et al.: Food Addit. Contam., 21, 737 (2004), Reffelmann, T., et al.: Curr. Pharm. Des., 12, 3485 (2006), Reepmeyer, J., et al.: J. Pharm. Biomed. Anal., 43, 1615 (2007),<br></p>Formula:C22H29N5O4SColor and Shape:NeatMolecular weight:459.56Haloperidol
CAS:Controlled Product<p>Applications Antidyskinetic; antipsychotic. Neuroprotective product.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Janicki, C.A., et al.: Anal. Profiles Drug Subs., 9, 341 (1980), Beresford, R., et al.: Drugs, 33, 31 (1987)<br></p>Formula:C21H23ClFNO2Color and Shape:Off-WhiteMolecular weight:375.86Thiazolylmethyl-4-nitrophenylcarbonate
CAS:Controlled Product<p>Applications Retinovir intermediate.<br>References Randad, R., et al.: Bioorg. Med. Chem. Lett., 4, 1247 (1994), Scholz, et al.: J. Med. Chem., 37, 3079 (1994), Vacca, J., et al.: Bioorg. Med. Chem. Lett., 4, 499 (1994),<br></p>Formula:C11H8N2O5SColor and Shape:Light YellowMolecular weight:280.26Desethylene Aripiprazole
CAS:<p>Impurity Aripiprazole Desethylene Impurity<br>Applications Desethylene Aripiprazole is an Aripiprazole derivative. Aripiprazole Desethylene Impurity<br></p>Formula:C21H25Cl2N3O2Color and Shape:NeatMolecular weight:422.35Ipragliflozin
CAS:Controlled Product<p>Applications Ipragliflozin is a potent and selective inhibitor of sodium-glucose cotransporter-2 (SGLT2) and can serve as a potential agent for the treatment of type 1 and type 2 diabetes.<br>References Kadokura, T., et al.: Clin. Pharmacokinet., 53, 975 (2014); Kashiwagi, A., et al.: J. Diabetes Investig., 5, 382 (2014); Tahara, A., et al.: J. Pharm. Pharmacol., 66, 975 (2014); Zhang, W., et al.: Clin. Drug Invest., 33, 489 (2013)<br></p>Formula:C21H21FO5SColor and Shape:WhiteMolecular weight:404.45Marbofloxacin-d8
CAS:Controlled Product<p>Applications Labelled fluorinated quinolone antibacterial.<br>References Gruet, P., et al.: Vet. Rec., 140, 199 (1977), Lefebvre, H.P., et al.: J. Vet. Pharmacol. Ther., 21, 453 (1998),<br></p>Formula:C172H8H11FN4O4Color and Shape:NeatMolecular weight:370.402,5-Dimethyl Celecoxib
CAS:Controlled Product<p>Applications A non-cyclooxygenase-2 inhibitor analog of Celecoxib (C251000). The celecoxib analog, 2,5-di-Me celecoxib (DMC), lacks COX-2 inhibitory activity but exhibits cytotoxic properties comparable to the COX-2 inhibitor Celecoxib.<br>References Deckmann, K. et al.: Biochem. Pharmacol., 80, 1365 (2010); Virrey, J.J. et al.: Mol. Cancer. Therap., 9, 631 (2010); Chen, S. et al.: Leukemia Res., 34, 250 (2010);<br></p>Formula:C18H16F3N3O2SColor and Shape:NeatMolecular weight:395.3987N-Formyl Lenalidomide
CAS:Controlled ProductFormula:C14H13N3O4Color and Shape:NeatMolecular weight:287.27Domperidone N-Oxide
CAS:Controlled Product<p>Impurity Domperidone EP Impurity C<br>Stability Hygroscopic<br>Applications Domperidone N-Oxide (Domperidone EP Impurity C) is an oxygenated metabolite of the gastrokinetic and antinauseant drug Domperidone (D531100).<br>References Van Vaeck, L. et al.: Biomed. Env. Mass Spec., 16, 121 (1988);<br></p>Formula:C22H24ClN5O3Color and Shape:White To Off-WhiteMolecular weight:441.91Tazarotene-d8
CAS:Controlled Product<p>Applications Labelled Tazarotene (T010050). An acetylenic retinoid prodrug converted to the active metabolite, Tazarotenic acid, with selective affinity for retinoic acid receptors RARβ and RARγ. Antiacne; antipsoriatic. Used in treatment of photodamaged skin.<br>References Tang-Liu, D.D.-S., et al.: Clin. Pharmacokinet., 37, 273 (1999), Roeder, A., et al.: Skin Pharmacol. Physiol., 17, 111 (2004),<br></p>Formula:C21H13D8NO2SColor and Shape:YellowMolecular weight:359.51Abemaciclib-D8
CAS:Controlled ProductFormula:C27D8H24F2N8Color and Shape:NeatMolecular weight:514.6436-(4-AMINO-4-METHYLPIPERIDIN-1-YL)-3-(2,3-DICHLOROPHENYL)PYRAZIN-2-AMINE
CAS:Purity:95.0%Molecular weight:352.260009765625Ref: 10-F544411
1gTo inquire5mgTo inquire10mgTo inquire25mgTo inquire50mgTo inquire100mgTo inquire250mgTo inquire4-Chloro-4'-fluorobutyrophenone
CAS:Controlled Product<p>Applications 4-Chloro-4'-fluorobutyrophenone (cas# 3874-54-2) is a compound useful in organic synthesis.<br></p>Formula:C10H10ClFOColor and Shape:NeatMolecular weight:200.64N-(3-Morpholinopropyl) Gefitinib
CAS:Controlled Product<p>Applications N-(3-Morpholinopropyl) Gefitinib is a Gefitinib (G304000) impurity. It can also be synthesized from O-Desmorpholinopropyl Gefitinib (D296830).<br>References Anderson, N.G., et al.: Int. J. Cancer, 94, 774 (2001); Hirata, A., et al.: Cancer Res., 62, 2554 (2002); Kris, M.G., et al.: J. Am. Med. Assoc., 290, 2149 (2003); Tamura, K., et al.: Expert Opin. Pharmacother., 6, 985 (2005); Ranson, M., et al.: J. Clin. Oncology, 20, 2240 (2002); Mendelsohn, J., et al.: J. Clin. Oncology, 21, 2787 (2003); McKillop, D., et al.: Xenobiotica, 10, 917 (2004);<br></p>Formula:C29H37ClFN5O4Color and Shape:NeatMolecular weight:574.0874-Nitrophenethylamine Hydrochloride
CAS:Formula:C8H10N2O2·HClColor and Shape:Light BeigeMolecular weight:166.18 + 36.466'-Methoxy-2'-acetonaphthone (Naproxen Impurity L)
CAS:Controlled Product<p>Impurity Naproxen USP Related Compound L<br>Applications Naproxen impurity L. Naproxen USP Related Compound L<br>References Boynton, C., et al.: J. Clin. Pharmacol., 28, 512 (1988), Li, J., et al.: J. Med. Chem., 39, 1846 (1996), Monser, L., et al.: J. Pharm. Biomed. Anal., 27, 851 (2002),<br></p>Formula:C13H12O2Color and Shape:BeigeMolecular weight:200.233(Z)-Thiothixene
CAS:Controlled Product<p>Applications Thiothixene is a modulator of human P-glycoprotein and is frequently used a an anti-psychotic.<br>References Janowsky, D. et al.: J. Chlin. Psych., 67, 1272 (2006); Siegel, S. et al.: Eur. J. Pharm. Bioharm., 64, 287 (2006);<br></p>Formula:C23H29N3O2S2Color and Shape:NeatMolecular weight:443.633-Pyridylmagnesium bromide, 0.25M THF
CAS:Purity:97.0%Color and Shape:LiquidMolecular weight:182.30299377441406O-Pentaacetyl O-Desethyl Dapagliflozin
CAS:Formula:C29H31ClO11Color and Shape:White To Off-WhiteMolecular weight:591.003Tadalafil-d3
CAS:Controlled Product<p>Stability Unstable in Methanol<br>Applications Tadalafil is used for the treatment of erectile dysfunction. A phosphodiesterase 5 inhibitor.<br>References Carrier, S., et al.: Can. J. Urol., 10(1), 12 (2003), Doggrell, S.A., et al.: Expert Opin. Pharmacother., 6, 75 (2005), Forgue, S.T., et al.: Br. J. Clin. Pharmacol., 61, 280 (2005),<br></p>Formula:C222H3H16N3O4Color and Shape:White SolidMolecular weight:392.422-Hydroxymethyl Loratadine
CAS:Controlled Product<p>Impurity Loratadine 2-Hydroxymethyl Impurity (USP)<br>Applications A usual impurity in Loratadine syrup formulations, a nonsedating-type histamine H1-receptor. Loratadine 2-Hydroxymethyl Impurity (USP).<br>References Okamoto, T., et al.: Chem. Pharm. Bull ., 7, 130 (1959), Eyjolfsson, R., et al.: Pharmazie, 58, 154 (2003),<br></p>Formula:C23H25ClN2O3Color and Shape:NeatMolecular weight:412.91Amantadine
CAS:Controlled Product<p>Applications Amantadine is useful in biology studies. Particularly it has been used for solid-state NMR and membrane protein studies.<br>References Shigeta, A., et al.: New Developments in NMR, 20, 457 (2019)<br></p>Formula:C10H17NColor and Shape:White To Off-WhiteMolecular weight:151.25(S)-Lisinopril Dimer
CAS:Controlled Product<p>Applications (S)-Lisinopril (L468985) impurity. Lisinopril Impurity G (Dimer Impurity)<br></p>Formula:C42H60N6O9Color and Shape:WhiteMolecular weight:792.96Maraviroc-d6
CAS:Controlled Product<p>Applications Potent, non-competitive CCR5 receptor antagonist; inhibits binding of HIV viral coat protein gp120. Antiviral.<br>References Fumero, E., et al.: Clin. Microbiol. Infect., 9, 1077 (2003), Walker, D.K., et al.: Drug Metab. Dispos., 33, 587 (2005), Wood, A., et al.: Prog. Med. Chem., 43, 239 (2005),<br></p>Formula:C29D6H35F2N5OColor and Shape:NeatMolecular weight:519.70Dechloro-Rivaroxaban
CAS:Controlled Product<p>Applications Dechloro-Rivaroxaban is an impurity of Rivaroxaban (R538000), which is a novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor.<br>References Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005),<br></p>Formula:C19H19N3O5SColor and Shape:NeatMolecular weight:401.444-Nitro Lenalidomide
CAS:Controlled Product<p>Impurity Lenalidomide impurity<br>Applications Lenalidomide (L328000) analog. Lenalidomide impurity; Lenalidomide intermediate.<br>References Hashimoto, Y., et al.: Bioorg. Med. Chem., 10, 461 (2002),<br></p>Formula:C13H11N3O5Color and Shape:NeatMolecular weight:289.244-Cyano-3-trifluoromethylphenylisothiocyanate
CAS:Controlled ProductFormula:C9H3F3N2SColor and Shape:NeatMolecular weight:228.192-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol
CAS:Controlled Product<p>Applications 2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol is an impurity found in Mirtazapine (M365000). Mirtazapine Impurity B.<br></p>Formula:C17H21N3OColor and Shape:White To Off-WhiteMolecular weight:283.372-(1-Hydroxyethyl) Promazine-d4
CAS:Controlled Product<p>Applications A labelled metabolite of Acepromazine (A130900).<br>References Cossum, P., et al.: Drug Dispos., 9, 321 (1988), Stowell, L., et al.: J. Anal. Toxicol., 22, 166 (1998),<br></p>Formula:C19H20D4N2OSColor and Shape:NeatMolecular weight:332.5Clozapine
CAS:Controlled Product<p>Applications An antipsychotic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Stille, et al: Farnaco, Ed. Prat., 26, 603 (1971), Hane, J.M., et al.: Psychopharmacol. Bull., 24, 62 (1988), Meltzer, H.Y.: J. Clin. Psychiatry, 55, Suppl. B, 47 (1994)<br></p>Formula:C18H19ClN4Color and Shape:Off-WhiteMolecular weight:326.82Lenalidomide-d5
CAS:Controlled Product<p>Applications Lenalidomide-d5, is the labeled analogue of Lenalidomide (L328000), an immunomodulatory drug; analog of Thalidomide.<br>References Bartlett, J.B., et al.: Nature Rev., 4, 314 (2004), Mitsiades, C.S., et al.: Curr. Opin. Invest. Drugs, 5, 635 (2004), List, A., et al.: N. Engl. J. Med., 352, 549 (2005),<br></p>Formula:C13H8D5N3O3Color and Shape:Off-WhiteMolecular weight:264.291-[4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]butyl] Aripiprazole
CAS:<p>Impurity Aripiprazole Impurity 4<br>Applications 1-[4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]butyl] Aripiprazole is a synthetic impurity of the drug aripiprazole (A771000). Aripiprazole is a novel atypical antipsychotic drug used in the treatment of schizophrenia. Aripiprazole Impurity 4<br>References Filijovic, N. D., et al.: Acta Chromatogr., 26, 13 (2014)<br></p>Formula:C36H42Cl2N4O4Color and Shape:White To Off-WhiteMolecular weight:665.649Captopril-d3
CAS:Controlled Product<p>Applications Orally active angiotensin-converting enzyme (ACE) inhibitor.<br>References Rubin, B., et al.: Eur. J Pharmacol., 51, 377 (1978),<br></p>Formula:C9D3H12NO3SColor and Shape:White SolidMolecular weight:220.302,3,4-Trimethoxybenzaldehyde
CAS:Controlled Product<p>Applications 2,3,4-Trimethoxybenzaldehyde is a trimethoxylated aromatic aldehyde. 2,3,4-Trimethoxybenzaldehyde is an impurity of the anti-anginal drug Trimetazidine (T795610).<br>References Medenica, M.B. et al.: J. Chrom. Sci., 46, 430 (2008);<br></p>Formula:C10H12O4Color and Shape:Off-WhiteMolecular weight:196.201-Hydroxycyclopentyl 2-chlorophenyl Ketone
CAS:Controlled ProductFormula:C12H13ClO2Color and Shape:Colourless To Light YellowMolecular weight:224.68Hydroxy Ritonavir
CAS:Controlled Product<p>Impurity Ritonavir EP Impurity E<br>Applications Hydroxy Ritonavir (Ritonavir EP Impurity E) is a metabolite of Ritonavir (R535000), HIV-1 protease inhibitor. It is a COVID19-related research product.<br>References Eagling, V., et al.: Br. J. Clin. Pharmacol., 48, 543 (1999), Eagling, V., et al.: Xenobiotica, 32, 1 (2002), Meaden, E., et al.: J. Antimicrob. Chemother., 50, 583 (2002), Treijtel, N., et al.: Drug Metab. Dispos., 33, 1325 (2005),<br></p>Formula:C37H48N6O6S2Color and Shape:NeatMolecular weight:736.94Intedanib
CAS:Controlled Product<p>Applications It is an indolinone derivative potently blocking VEGF-, PDGF-, and FGF-receptor kinases; an indolinone as triple angiokinase inhibitors. An antitumor agent.<br>References Sun, L., et al.: J. Med. Chem., 41, 2588 (1998); Xie, H., et al.: J. Med. Chem., 50, 4898 (2007); Hilberg, F., et al.: Cancer Res., 68, 4774 (2008); Roth, G., et al.: J. Med. Chem., 58, 1053 (2015)<br></p>Formula:C31H33N5O4Color and Shape:NeatMolecular weight:539.624-(3,5-dimethyl-1H-pyrazol-1-yl)benzenesulfonyl chloride
CAS:Color and Shape:SolidMolecular weight:270.73001098632815-(1-Methyl-4-piperidinyl)-5H-dibenzo[a,d]cyclohepten-5-ol
CAS:Controlled Product<p>Applications 5-(1-Methyl-4-piperidinyl)-5H-dibenzo[a,d]cyclohepten-5-ol is a derivative of Cyproheptadine (C989200) which is a first-generation antihistamine with additional anticholinergic, antiserotonergic, and local anesthetic properties. Cyproheptadine is a 5-HT2/5-HT1C serotonin receptor antagonist; H1 histamine receptor antagonist; antipruritic.<br>References Marchei, E., et al.: J. Pharm. Biomed. Anal., 41, 1633 (2006); de-Benedictis, F., et al.: Allergy, 63, 1395 (2008); Feas, X., et al.: J. Pharm. Biomed. Anal., 50, 1044 (2009); Yu, C., et al.: Talanta, 2011, 83, 1376 (2011);<br></p>Formula:C21H23NOColor and Shape:NeatMolecular weight:305.41Benzophenone-2,3,4,5,6-d5
CAS:Controlled Product<p>Applications Benzophenone-2,3,4,5,6-d5 is derived from Benzene-d6 (B185282), which is an isotope labelled benzene, an organic compound that is a natural constituent of crude oil and one of the most basic petrochemicals.<br>References Feng, Z.X.. et al.: J. Phys. Chem. Lett. 4, 285 (2013); Pilling. M., et al.: Chem. Eng. Prog., 108, 32 (2012);<br></p>Formula:C13D5H5OColor and Shape:NeatMolecular weight:187.25Riluzole 4-Trifluoromethoxy Isomer
CAS:Controlled Product<p>Applications Riluzole 4-Trifluoromethoxy Isomer is an impurity of Riluzole (R510000), a neuroprotective agent. Modulates glutamatergic transmission. A glutamate release inhibitor. An anticonvulsant.<br>References Satyanarayana, B., et. al.: ARKIVOC, 14, 109 (2008); Mizoule, J., et al.: Neuropharmacology, 24, 767 (1985), Wahl, F., et al.: Eur. J. Pharmacol., 230, 209 (1993) Bensimon, G., et al.: N. Engl. J. Med., 330, 585 (1994)<br></p>Formula:C8H5F3N2OSColor and Shape:NeatMolecular weight:234.206-chloro-2-(3-methylphenyl)quinoline-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:297.739990234375Suprofen
CAS:<p>Applications Prostaglandin biosynthesis inhibitor. Analgesic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Niemegeers, C.J.E., et al.: Arzneim.-Forsch., 25, 1537 (1975),<br></p>Formula:C14H12O3SColor and Shape:BeigeMolecular weight:260.31S-(-)-Etomidate
CAS:Controlled Product<p>Applications Etomidate (E933300) is a hypnotic. This is a stereoisomer.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Goetz, E., et al.: Anaesthesist, 23, 331 (1974), Chang, Z. L., et al.: Anal. Profiles Drug Subs., 12, 191 (1983),<br></p>Formula:C14H16N2O2Color and Shape:NeatMolecular weight:244.294-tert-Butylaminoethyl-2-methylphenol
CAS:Controlled Product<p>Impurity Salbutamol EP Impurity H<br>Applications 4-tert-Butylaminoethyl-2-methylphenol (Salbutamol EP Impurity H) is an impurity of Albuterol Sulfate (Salbutamol Sulfate) (A514500). Albuterol impurity H.<br>References Epshtein, N., et al.: Pharm. Chem. J., 38, 212 (2004), Erram, S., et al.: J. Pharm. Biomed. Anal., 40, 864 (2006),<br></p>Formula:C13H21NOColor and Shape:NeatMolecular weight:207.31N-(4-Aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide
CAS:Formula:C14H22N4OColor and Shape:Off-White To BeigeMolecular weight:262.35Amantadine-d15 Hydrochloride
CAS:Controlled Product<p>Applications NMDA-receptor antagonist. Antiviral; antiparkinsonian.<br>References Vernier, V.G., et al; Toxicol. Appl. Pharmacol., 15, 642 (1969), Kirschbaum, J., et al.: Anal. Profiles Drug Subs., 12, 1 (1983),<br></p>Formula:C102H15H2NColor and Shape:NeatMolecular weight:166.34Didesmethyl Cariprazine
CAS:Controlled Product<p>Applications Didesmethyl Cariprazine, s a derivative of Cariprazine (C183490) which is an orally active D2/D3 dopamine receptor antagonist (1,2,3). Cariprazine is an antipsychotic drug candidate for the potential treatment of schizophrenia, bipolar mania and depression.<br>References Gruender, G.: Curr. Opin. Invest. Drugs, 11, 823 (2010); Seneca, N. et al.: Psychopharmacology, 218, 579 (2011); Kiss, B. et al.: J. Pharmacol. Exp. Therap., 333, 328 (2010)<br></p>Formula:C19H28Cl2N4OColor and Shape:NeatMolecular weight:399.36Prulifloxacin
CAS:<p>Applications Prulifloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Prulifloxacin is a prodrug for active metabolite, Ulifloxacin. Antibacterial.<br>References Ozaki, M., et al.: Antimicrob. Agents Chemother., 35, 2496 (1991), Segawa, J., et al.: J. Med. Chem., 35, 4727 (1992), Nakashima, M., et al.: J. Clin. Pharmacol., 34, 930 (1994),<br></p>Formula:C21H20FN3O6SColor and Shape:NeatMolecular weight:461.46N-Nitroso Paroxetine
CAS:Formula:C19H19FN2O4Color and Shape:White To Light YellowMolecular weight:358.364rac-Vigabatrin-13C,d2 (Major)
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Labelled Vigabatrin. A novel antiepileptic drug. Antidepressant; antipsychotic; anxiolytic.<br>References Vajda, F., et al.: Clin. Neurosci., 7, 88 (2000), Beghi, E., et al.: Lancet. Neurol., 3, 618 (2004), Sagirli, O., et al.: J. Pharmaceut. Biomed., 42, 618 (2006),<br></p>Formula:C513CH9D2NO2Color and Shape:White To Dark YellowMolecular weight:132.16Nizatidine-d3
CAS:Controlled Product<p>Applications Labelled Nizatidine. Histamine H2-receptor antagonist related to Ranitidine (R120000). Antiulcerative.<br>References Callaghan, J.T., et al.: Clin. Pharmacol. Ther., 37, 162 (1985), Secor, J.W., et al.: Br. J. Clin. Pharmacol., 20, 710 (1985), Knadler, M.P., et al.: Drug Metab. Dispos., 14, 175 (1986), Wozniak, T.J., et al.: Anal. Profiles Drug Subs., 19, 397(1990)<br></p>Formula:C12D3H18N5O2S2Color and Shape:Light Yellow SolidMolecular weight:334.48Demethylpiperazinyl 7-Desoxo 7-Thioxosildenafil Sulfonic Acid
CAS:Controlled ProductFormula:C17H20N4O4S2Color and Shape:Off White SolidMolecular weight:408.50Carisoprodol
CAS:Controlled Product<p>Applications Muscle relaxant (skeletal).<br>References Musso, D., et al.: J. Med. Chem. 46, 399 (2003), Newman, P., et al.: Eur. J. Clin. Pharm., 23, 31 (1982).<br></p>Formula:C12H24N2O4Color and Shape:White To Off-WhiteMolecular weight:260.33Mirtazapine N-Glucuronide (Mixture of Diastereomers) Contains Unknown Inorganics >80%
CAS:Controlled Product<p>Applications Mirtazapine N-Glucuronide is a metabolite of Mirtazapine (M365000), an α2-Adrenergic blocker; analogue of Mianserin. Antidepressant.<br>References Smith, D.A., RSC Drug Discovery Series, 1, 193 (2010); De Boer, T., et al.: Neuropharmacology, 27, 399 (1988); Smith, W.T., et al.: Psychopharmacol. Bull., 26, 191 (1990)<br></p>Formula:C23H28N3O6Purity:>80%Color and Shape:NeatMolecular weight:442.48O-Ethyl Albuterol
CAS:Controlled Product<p>Impurity Levalbuterol USP Related Compound E<br>Applications O-Ethyl Albuterol is an analog of Albuterol (A514500). A β2-adrenoceptor agonist. Bronchodilator; tocolytic. Levalbuterol USP Related Compound E.<br>References Han, et al.: Bioorg. Med. Chem., 14, 6043 (2006), Liyou, H., et al.: Biochem., 46, 1432 (2007), Agrawal, D., et al.: J. Allergy Clin. Immunol., 113, 503 (2004),<br></p>Formula:C15H25NO3Color and Shape:NeatMolecular weight:267.36(S)-Naproxen Sodium Salt
CAS:<p>Applications An anti-inflammatory, analgesic, antipyretic. A non-steroidal anti-inflammatory.<br>References Harrison, I.T., et al.: J. Med. Chem., 13, 203 (1970)<br></p>Formula:C14H13O3·NaColor and Shape:Off White SolidMolecular weight:252.24(R)-Naproxen Acyl-β-D-glucuronide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A metabolite of Naproxen.<br>References Boynton, C., et al.: J. Clin. Pharmacol., 28, 512 (1988), Jin, C., et al.: J. Pharmacol. Exp. Ther., 264, 475 (1993),King, C., et al.: Toxicol. Sci., 61, 49 (2001), Aresta, A., et al.: J. Pharm. Biomed. Anal., 39, 643 (2005),<br></p>Formula:C20H22O9Color and Shape:NeatMolecular weight:406.38Perazine Dihydrochloride
CAS:<p>Applications Antipsychotic.<br>References Hromatka, et al.: Monatsh. Chem., 88, 56 (1957), Franke, U., et al.: J. Pharm. Sci., 88, 89 (1999), Hashem, H., et al.: Pharmazie, 60, 186 (2005),<br></p>Formula:C20H25N3S·2ClHColor and Shape:NeatMolecular weight:412.42Acalabrutinib
CAS:Controlled Product<p>Applications Acalabrutinib, is an experimental anti-cancer drug and a selective Bruton's tyrosine kinase (BTK) inhibitor. This kinase transmits signals from B-cell Receptor (BCR), and thus any genetic BTK mutation causes B-Cell immunodeficiency. Therefore, BTK inhibitors targeting B-cell signaling has shown great promise for the treatment of chronic lymphocytic leukemia (CLL).<br>References Byrd; et al. (2015). "Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia."; "AstraZeneca to buy Acerta for blood cancer drug". www.rsc.org. Chemistry World - Royal Society of Chemistry. Retrieved 24 December 2015.<br></p>Formula:C26H23N7O2Color and Shape:NeatMolecular weight:465.514-Bromo-2-chloro-3-iodopyridine
CAS:Formula:C5H2BrClINPurity:98%Color and Shape:Brown powderMolecular weight:318.343-Cyclopropylmethoxy-4-difluoromethoxybenzoic Acid
CAS:Controlled Product<p>Applications An impurity and intermediate in the preparation of selective phosphodiesterase 4 (PDE4) inhibitor, Roflumilast (R639700).<br></p>Formula:C12H12F2O4Color and Shape:NeatMolecular weight:258.22Ketoconazole
CAS:Controlled Product<p>Applications Inhibits cytochrome P-450 dependent steps in the biosynthesis of steroid hormones in vivo. Antimetastatic and antineoplastic activity. Orally active 5-lipoxygenase and thromboxane synthase inhibitor. Inhibitor of exosome secretion.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lambert, A., et al.: Biochem. Pharmacol., 35, 3999 (1986), Van Wauwe, J.P. and Janssen, P.A.J., J. Med. Chem., 32, 2231 (1989), Nardone, P.A., et al.: . Surg. Res., 44, 425 (1988), Tucker, W.F.G., et al.: Br. Med. J., 293, 882 (1986); Scientific Reports 8: 8161 (2018)<br></p>Formula:C26H28Cl2N4O4Color and Shape:NeatMolecular weight:531.43Etoricoxib-d6
CAS:Controlled Product<p>Applications Etoricoxib-d6 is the labelled analog of Etoricoxib (E934100), a specific inhibitor of COX-2 .<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References McGeer, P.L., et al.: Exp. Gerontol., 37, 925 (2002), Chenevard, R., et al.: Circulation, 107, 405 (2003)<br></p>Formula:C18H9D6ClN2O2SColor and Shape:NeatMolecular weight:364.88Irbesartan-d7 2,2,2-Trifluoroacetate Salt
CAS:Controlled ProductFormula:C25D7H21N6O·C2HF3O2Color and Shape:NeatMolecular weight:549.60Aprepitant N-Oxide
CAS:Controlled ProductFormula:C23H21F7N4O4Color and Shape:NeatMolecular weight:550.426Benzidine
CAS:Controlled Product<p>Applications Potentially mutagenic compound. Dyes and metabolites, Environmental Testing.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Dairou, J., et al.: Toxicol. App. Pharmacol., 236, 366 (2009), Toropov, A., et al.: Chem. Biol. Drug Design, 73, 482 (2009),<br></p>Formula:C12H12N2Purity:95%Color and Shape:Tan Or Dark Grey To BlackMolecular weight:184.24Prochlorperazine Dimaleate
CAS:Controlled ProductFormula:C20H24ClN3S·2C4H4O4Color and Shape:Off-WhiteMolecular weight:606.09Anastrozole Acid Amide
<p>Applications Anastrozole Acid Amide is a derivative of Anastrozole (A637425), an aromatase inhibitor. Used as an antineoplastic.<br>References Plourde, P.V., et al.: Breast Cancer Res. Treat., 30, 103 (1994), Buzdar, A.U., et al.: Cancer, 79, 730 (1997)<br></p>Formula:C17H22N4O3Color and Shape:NeatMolecular weight:330.38Propyzamide
CAS:Controlled Product<p>Applications Selective pre-emergence herbicide.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Viste, K.L., et al.: Science, 167, 280 (1970), Yoshii, K., et al.: J. Agric. Food Chem., 48, 2502 (2000), Paya, P., et al.: Anal. Bioanal. Chem., 389, 1697 (2007),<br></p>Formula:C12H11Cl2NOColor and Shape:WhiteMolecular weight:256.13tert-Butyl (R)-3-Aminopiperidine-1-carboxylate
CAS:Controlled Product<p>Applications tert-Butyl (R)-3-Aminopiperidine-1-carboxylate, is an heterocyclic building block used for the synthesis of more complex pharmaceutical compounds. It is also found to act as a γ-secretase modulators, and a potent structure for lowering Aβ42 production in both in vitro and in vivo.<br>References Kobayashi, T., et al.: Bioorg. Med. Chem. Lett., 24, 378 (2014);<br></p>Formula:C10H20N2O2Color and Shape:NeatMolecular weight:200.28Bis[(2-guanidino-4-thiazolyl)methyl]disulfide (85%) (Famotidine Impurity)
CAS:Controlled ProductFormula:C10H14N8S4Color and Shape:Off-WhiteMolecular weight:374.53Timolol Maleate
CAS:<p>Applications Antihypertensive; antiarrhythmic (class II); antianginal; antiglaucoma agent.<br>References Wasson, et al.: J. Med. Chem., 15, 651 (1972), Franciosa, et al.: Clin. Pharmacol. Ther., 13, 138 (1972), Heel, R.C., et al.: Drugs, 17, 38 (1979), Rofman, B.A., et al.: Hypertension, 2, 643 (1980), Mazzo, D.J., et al.: Anal. Profiles Drug Subs., 16, 641 (1987),<br></p>Formula:C13H24N4O3S·C4H4O4Color and Shape:NeatMolecular weight:432.49Methyl 2-Sulfamoylbenzoate
CAS:<p>Applications Methyl 2-Sulfamoylbenzoate is a building block used in various synthetic preparations. It is also classified as a pollutant found in a municipal wastewater treatment plant.<br>References Hollender, J., et al.: Environ. Sci. Technol., 43, 7862 (2009);<br></p>Formula:C8H9NO4SColor and Shape:NeatMolecular weight:215.23Ritonavir-13C3
CAS:Controlled Product<p>Applications A stable labelled selective HIV protease inhibitor Ritonavir (R535000). It is a COVID19-related research product.<br>References Daluge, S., et al.: Antimicrob. Agents Chemother., 38, 1590 (1994), Ammaranond, P., et al.: J. Clin. Virol., 26, 153(2003), Harrigan, P., et al.: J. Infect. Dis., 191, 339 (2005), Miller, J., et al.: Bioorg. Med. Chem. Lett., 16, 1788 (2006)<br></p>Formula:C3C34H48N6O5S2Color and Shape:NeatMolecular weight:723.92Amisulpride-d5
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Labelled Amisulpride (A633250). Amisulpride is a neuroleptic agent, an analogue of Sulpiride (S689145). Amisulpride is used as an antipsychotic. Amisulpride is a dopamine receptor antagonist.<br>References Protais, P., et al.: Neuropharmacol., 24, 861 (1985), Perrault, G., et al.: J. Pharmacol. Exp. Ther., 280, 73 (1997),<br></p>Formula:C17D5H22N3O4SColor and Shape:Off White SolidMolecular weight:374.51Iso Rizatriptan
CAS:Controlled Product<p>Impurity Rizatriptan EP Impurity C<br>Applications Iso Rizatriptan (Rizatriptan EP Impurity C) is a potential impurity of Rizatriptan. A regioisomer of Rizatriptan.<br>References Dill, K., et al.: J. Phys. Chem., 91, 1980 (1987), Cole, L., et al.: Anal. Chem., 64, 1317 (1992), Street, L., et al.: J. Med. Chem., 1995, 38, 1799<br></p>Formula:C15H19N5Color and Shape:NeatMolecular weight:269.34(S)-5-Bromo Naproxen
CAS:Controlled ProductFormula:C14H13BrO3Color and Shape:NeatMolecular weight:309.166-methyl-2-(3-methylphenyl)quinoline-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:277.322998046875Simendan
CAS:Controlled Product<p>Applications Simendan is the racemic mixture of Levosimendan (L378000) which is a positive inotropic agent with vasodilating activity.<br>References Sandell, E.-P., et al.: J. Cardiovasc. Pharmacol., 26, S57 (1995); Pagel, P.S., et al.: Cardiovasc. Drug Rev., 14, 286 (1996)<br></p>Formula:C14H12N6OColor and Shape:Yellow SolidMolecular weight:280.281,1'-(1,3-Phenylene)bis-1H-1,2,4-triazole
CAS:Controlled Product<p>Impurity Fluconazole EP Impurity C / Fluconazole USP Related Compound C<br>Stability Light Sensitive<br>Applications 1,1'-(1,3-Phenylene)bis-1H-1,2,4-triazole (Fluconazole EP Impurity C) is a Fluconazole (F421000) impurity.<br>References Bauer, M., et al.: Eur. J. Pharma. Sci., 6, 331 (1998), Dongre, V., et al.: J. Pharma. Biomed. Anal., 42, 334 (2006),<br></p>Formula:C10H8N6Color and Shape:BeigeMolecular weight:212.21Furazolidone
CAS:<p>Applications Antimicrobial.Environmental contaminants; Food contaminants; Heat processing contaminants<br>References Yurchenco, J.A., et al.: Antimicrob. Chemother., 3, 1035 (1953), Sharma, C., et al.: J. Clin. Microbiol., 36, 756 (1998),<br></p>Formula:C8H7N3O5Color and Shape:YellowMolecular weight:225.162-(Acetylamino)-6-[[[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]amino]carbonyl]-benzoic Acid
CAS:Controlled ProductFormula:C22H26N2O8SColor and Shape:NeatMolecular weight:478.527-Chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid, 90%
CAS:Controlled Product<p>Impurity Norfloxacin EP Impurity A; Norfloxacin USP Related Compound A (7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-d<br>Applications 7-Chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid (Norfloxacin EP Impurity A) is a Norfloxacin intermediate. Norfloxacin EP Impurity A; Norfloxacin USP Related Compound A (7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid).<br>References Piganeau, N., et al.: J. Mol. Biol., 312, 1177 (2001), Rameshkumar, N., et al.: Eur. J. Med. Chem., 38, 1001 (2003), You, Q., et al.: J. Med. Chem., 52, 5649 (2009),<br></p>Formula:C12H9ClFNO3Purity:90%Color and Shape:NeatMolecular weight:269.664-(4-Amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide
CAS:Controlled Product<p>Applications 4-(4-Amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide is a compound used as a reagent to synthesize Regorafenib (R143000), a multikinase inhibitor that is used to treat patients with advanced colorectal cancer.<br>References Mross, K., et al.: Clin. Cancer Res., 18, 2658 (2012); Stiehl, J., et al. Process for Preparation of Regorafenib. PCT Int. Appl. 2011128261. Oct 20, 2011; Van Cutsem, E., et al.: J. Clin. Oncol., 30, 3502 (2012)<br></p>Formula:C13H12FN3O2Color and Shape:Dark Orange To Red BrownMolecular weight:261.25rac Kynurenine
CAS:Controlled Product<p>Applications A tryptophan metabolite, is a precursor of kynurenic acid, which is an antagonist of N-methyl-aspartate receptor. An amino acid produced in the body from tryptophan.<br>References Swartz, K., et al.: J. Neurosci., 10, 2965 (1990), Hasegawa, H., et al.: Anal. Bioanal. Chem., 377, 886 (2003), Tsai, Y., et al.: Anal. Biochem., 319, 34 (2003), Mitsuhashi, S., et al.: Anal. Chim. Acta, 584, 315 (2007),<br></p>Formula:C10H12N2O3Color and Shape:NeatMolecular weight:208.21Quinoline Yellow (Technical Grade)
CAS:<p>Stability Hygroscopic<br>Applications Quinoline yellow, is a yellow powder used in lipstick, lotion, soap, shampoo, bubble bath, ingested drugs, and applied drugs applications.<br></p>Formula:C18H9NNa2O8S2Color and Shape:NeatMolecular weight:477.385-Chloro-2-Thiophenecarboxylic Acid 4-Nitrophenyl Ester
CAS:Controlled ProductFormula:C11H6ClNO4SColor and Shape:NeatMolecular weight:283.69Nilotinib
CAS:<p>Applications Nilotinib (AMN1O7) might be useful in treatment of chronic myelogenous leukemia. It is a COVID19-related research product.<br>References Corbin, A., et al.: J. Biol. Chem., 277, 32214(2002), Golemovic, M., et al.: Clin. Cancer Res., 11, 4941 (2005), Gleixner, K., et al.: Blood, 107, 752 (2006), Nicolini, F., et al.: Leukemia, 20, 1061 (2006),<br></p>Formula:C28H22F3N7OColor and Shape:Light Yellow To BeigeMolecular weight:529.52Valdecoxib-13C2,15N
CAS:Controlled ProductFormula:C2C14H1415NNO3SColor and Shape:NeatMolecular weight:317.34N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide
CAS:Formula:C21H35NO3Color and Shape:NeatMolecular weight:349.51rac 8,14-Dihydroxy Efavirenz
CAS:Controlled ProductFormula:C14H9ClF3NO4Color and Shape:NeatMolecular weight:347.67
![1-[4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]butyl] Aripiprazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FT310270.webp&w=3840&q=75)
![5-(1-Methyl-4-piperidinyl)-5H-dibenzo[a,d]cyclohepten-5-ol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM321260.webp&w=3840&q=75)
![Bis[(2-guanidino-4-thiazolyl)methyl]disulfide (85%) (Famotidine Impurity)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB439800.webp&w=3840&q=75)
![2-(Acetylamino)-6-[[[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]amino]carbonyl]-ben…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA168785.webp&w=3840&q=75)
